Libtayo 350 mg

Call for Price

Libtayo Cemiplimab 350 mg price in india best at online on yourmedikart.

Generic name: Cemiplimab-rwlc [ se-MIP-li-mab]
Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Libtayo is a medicine used to treat skin cancer by working with your immune system.

Libtayo Cemiplimab 350 mg price in india best at online on yourmedikart.

Generic name: Cemiplimab-rwlc [ se-MIP-li-mab]
Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Libtayo is a medicine used to treat skin cancer by working with your immune system. Libtayo 350 mg, known for its active ingredient cemiplimab, is a significant advancement in cancer treatment. The cost of Libtayo and cemiplimab price in India are critical considerations for patients and healthcare providers.

Despite its benefits, Libtayo side effects and specific libtayo dosing requirements should be well-understood. For more information on Libtayo price and therapeutic use, visit the detailed product page.

Cemiplimab 350 mg

Similarly Libtayo is used to treat a certain type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread to other parts of the body or cannot be treated with radiation or surgery.

Libtayo is used to treat a type of skin cancer called basal cell carcinoma (BCC) that cannot be removed by surgery (locally advanced BCC), or has spread to other parts of the body (metastatic BCC), and you have received treatment with a hedgehog pathway inhibitor (HHI), or if you cannot receive treatment with a HHI.

Libtayo 350 mg price

What is Libtayo?

If you have a certain kind of skin or lung cancer, your doctor may recommend Libtayo to treat your condition.

Libtayo is a prescription medication that’s used in adults to treat the following kinds of cancer in certain situations:

  • Cutaneous squamous cell carcinoma
  • Basal cell carcinoma
  • Non-small cell lung cancer

To use Libtayo, these cancers must be locally advanced or metastatic. With locally advanced forms, the cancer has spread into nearby tissues. With metastatic forms, the cancer has spread to other parts of your body. To learn more about the uses of Libtayo, see “What is Libtayo used for?” below.

How is Libtayo given?

Libtayo 350 mg is given as an infusion into a vein. A healthcare provider will give you this injection.

This medicine must be given slowly, and the infusion can take at least 30 minutes to complete.

Libtayo is usually given once every 3 weeks until your body no longer responds to the medication.

You will need frequent medical tests.

Libtayo basics

Libtayo is a kind of immunotherapy drug (treatment that helps your immune system attack cancer cells). It contains the active ingredient cemiplimab-rwlc.* (An active ingredient is what makes a drug work.)

Libtayo 350 mg is a biologic medication, which means it’s made using parts of living organisms Source. It’s not available in a biosimilar form. (Biosimilars are like generic drugs. But unlike generics, which are exact copies of nonbiologic drugs, biosimilars are “similar” to biologic drugs.) Instead, cemiplimab-rwlc is only available as the brand-name drug Libtayo.

A healthcare professional will give you Libtayo as an intravenous (IV) infusion, which is an injection into your vein given over a period of time. You’ll receive Libtayo infusions every 3 weeks at a doctor’s office, clinic, or infusion center.

Dosing information

Usual Adult Dose for Squamous Cell Carcinoma:

Libtayo Cemiplimab 350 mg IV over 30 minutes every 3 weeks until disease progression or unacceptable toxicity

Use: For the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation

Usual Adult Dose for Basal Cell Carcinoma:

Libtayo 350 mg IV over 30 minutes every 3 weeks until disease progression or unacceptable toxicity

Uses:
-For locally advanced basal cell carcinoma (laBCC) previously treated with a hedgehog pathway inhibitor or for whom a hedgehog pathway inhibitor is not appropriate
-For metastatic BCC (mBCC) previously treated with a hedgehog pathway inhibitor or for whom a hedgehog pathway inhibitor is not appropriate

Usual Adult Dose for Non-Small Cell Lung Cancer:

350 mg IV over 30 minutes every 3 weeks until disease progression or unacceptable toxicity

Uses:
-in combination with platinum-based chemotherapy for the first-line treatment of adult patients with locally advanced (where patients are not candidates for surgical resection or definitive chemoradiation) or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations
-as single agent for the first-line treatment of adult patients with locally advanced (where patients are not candidates for surgical resection or definitive chemoradiation) or metastatic NSCLC whose tumors have high PD-L1 expression [Tumor Proportion Score (TPS) = 50%] as determined by an FDA-approved test, with no EGFR, ALK or ROS1 aberrations

Before taking this medicine

To make sure Libtayo is safe for you, tell your doctor if you have ever had:

  • An immune system disorder such as lupus, ulcerative colitis, or Crohn’s disease
  • A nervous system problem, such as myasthenia gravis or Guillain-Barré syndrome
  • Radiation treatment to your chest area; or
  • An organ transplant

Tell your doctor if you have received or plan to receive a stem cell transplant using donor stem cells.

Libtayo 350 mg You may need to have a negative pregnancy test before starting Libtayo.

Cemiplimab 350 mg may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 4 months after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed while using Libtayo, and for at least 4 months after your last dose.

Libtayo side effects

Get emergency medical help if you have signs of an allergic reaction to Libtayo: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include fever, swollen glands, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling.

Libtayo 350 mg Some side effects Cemiplimab price may occur during the injection. Libtayo Cemiplimab 350 mg price in india best at online on yourmedikart.  Tell your caregiver right away if you feel dizzy, shaky, light-headed, nauseated, chilled or feverish, itchy, tingly, or have a rash, neck or back pain, trouble breathing, or swelling in your face.

Cemiplimab-rwlc strengthens your immune system to help your body fight against cancer cells. This may cause the immune system to attack normal healthy tissues or organs. When this happens, Cemiplimab price you may develop serious or life-threatening medical problems.

Call your doctor at once if you have:

  • New or worsening cough, shortness of breath.
  • Painful sores in your nose or genital area
  • Libtayo 350 mg Chest pain, fast or irregular heartbeats.
  • Swollen glands.
  • Severe headache, confusion, memory problems, Hallucinations.
  • Eye pain or redness, vision problems (your eyes may be more sensitive to light)
  • Severe muscle pain or weakness, neck stiffness, problems with balance
  • Severe stomach pain, nausea, vomiting, diarrhea, bloody or tarry stools
  • Unusual bruising
  • transplant rejection – mouth sores, stomach pain, feeling sick or uneasy, rash, pain or swelling near your transplanted Organ.
  • kidney problems – swelling in your ankles, blood in your urine, little or no Urination.
  • liver problems – right-sided upper stomach pain, loss of appetite, drowsiness, easy bruising or bleeding, dark urine, jaundice (yellowing of the skin or eyes); or
  • signs of a hormonal disorder – Cemiplimab price frequent or unusual headaches, dizziness, feeling very tired, mood or behavior changes, hoarse or deepened voice, increased hunger or thirst, increased urination, constipation, hair loss, sweating, feeling cold, weight gain, or weight loss.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common Libtayo side effects may include:

  • Tiredness
  • Hair loss
  • Numbness, pain, tingling or burning in your hands or feet.
  • Muscle or bone pain
  • Rash; or
  • Nausea, diarrhea, loss of appetite.

Libtayo 350 mg This is not a complete list of side effects and others may occur. Libtayo Cemiplimab 350 mg price in india best at online on yourmedikart. Call your doctor for medical advice about side effects. You may report side effects to FDA

What are Libtayo side effects?

Like most drugs, Libtayo may cause mild or serious side effects. Cemiplimab price The lists below describe some of the more common side effects that Libtayo may cause. These lists don’t include all possible side effects.

Keep in mind that side effects of a drug can depend on:

  • Your age
  • Other health conditions you have
  • Other Medications you take

Your doctor or pharmacist can tell you more about the potential side effects of Libtayo 350 mg price. They can also suggest ways to help reduce side effects.

Mild side effects

Here’s a list of some of the mild side effects that Libtayo 350 mg price can cause. Libtayo 350 mg To learn about other mild side effects of the drug, talk with your doctor or pharmacist, or read Libtayo prescribing information.

Mild side effects of Libtayo that have report include:

  • Fatigue (low energy)
  • Diarrhea
  • Nausea and vomiting
  • Skin rash
  • Itchiness
  • Pain in your muscles, bones, or joints
  • Cough
  • Loss of appetite
  • Mild infections, such as the common cold or urinary tract infections (UTIs)
  • Headache
  • Mild allergic reaction

* An allergic reaction is possible after using Libtayo. But this side effect wasn’t report in studies. To learn more about this side effect, see the “Allergic reaction” section below.

Libtayo 350 mg Mild side effects of many drugs may go away Cemiplimab 350 mg price within a few days to a couple of weeks. But if they become bothersome, talk with your doctor or pharmacist.

Serious side effects

Serious side effects from Libtayo can occur, Libtayo 350 mg price but they aren’t common. Similarly If you have serious side effects from Libtayo, call your doctor right away. But if you think you’re having a medical emergency, you should call 911 or your local emergency number.

Serious side effects of Libtayo that have report include:

  • Firstly Serious infections, such as pneumonia, cellulitis, and sepsis
  • Libtayo 350 mg Problems caused by your immune system attacking healthy tissues in your body, such as your lungs, kidneys, liver, intestines, and skin
  • Thirdly Problems caused by your immune system attacking hormone-producing glands in your body, such as your thyroid, adrenal, and pituitary glands.
  • Infusion reactions, such as trouble breathing, skin rash, nausea, and fever.
  • High blood pressure
  • Low red blood cell count
  • Low level of lymphocytes, a kind of white blood cell
  • Changes in the levels of Electrolytes (essential minerals, such as sodium and potassium) in the blood
  • Severe allergic reaction

FAQ

What is the use of Libtayo?

LIBTAYO (Lib-TIE-oh) is a prescription drug used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has not spread outside the body. surgery is not possible. or chemotherapy and radiation therapy, or lung cancer has spread to other areas

Is LIBTAYO safe?

Is LIBTAYO chemotherapy?

LIBTAYO is the first drug approved by the Food and Drug Administration (FDA) to treat CSCC that has spread or cannot be treated with surgery or radiation therapy. LIBTAYO is a type of immunotherapy called a programmed death receptor-1 (PD-1) inhibitor. LIBTAYO is not chemotherapy or radiotherapy.

Does LIBTAYO cause hair loss?

Common side effects of LIBTAYO when used with platinum-based chemotherapy drugs include: Hair loss. Muscle or bone pain. Nausea.

What kind of drug is LIBTAYO?

Libtayo is an anti-cancer drug. Libtayo is used in adults to treat a type of skin cancer called advanced cutaneous squamous cell carcinoma (CSCC) in the upper region or metastatic basal cell carcinoma (BCC), after receiving treatment with Hedgehog pathway inhibition.

 

WhatsApp us